Sanjay Chanda Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sanjay Chanda.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sanjay Chanda. Sanjay Chanda is SVP, Drug Development in Anacor Pharmaceuticals, Inc. ($ANAC) and VP, Int. Head of Drug Dev. in Anacor Pharmaceuticals, Inc. ($ANAC).
Latest Insider Trading Transactions of Sanjay Chanda
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.55 | 48 | 362 | 13,552 | |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.25 | 4,952 | 35,902 | 0 | |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 45.00 | 48 | 2,160 | 29,087 | 29.1 K to 29.1 K (-0.16 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.55 | 48 | 362 | 29,135 | 29.1 K to 29.1 K (+0.17 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 45.00 | 4,952 | 222,840 | 29,087 | 34 K to 29.1 K (-14.55 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.25 | 4,952 | 35,902 | 34,039 | 29.1 K to 34 K (+17.02 %) |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | A | 0.00 | 1,475 | 0 | 1,475 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | A | 37.81 | 20,845 | 788,149 | 20,845 | |
| Feb 05 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Grant | A | 0.00 | 5,020 | 0 | 29,087 | 24.1 K to 29.1 K (+20.86 %) |
| Dec 22 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 5.59 | 12,062 | 67,427 | 14,938 | |
| Dec 22 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 6.92 | 7,011 | 48,516 | 18,489 | |
| Dec 22 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 5.59 | 12,062 | 67,427 | 23,068 | 11 K to 23.1 K (+109.59 %) |
| Dec 22 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 6.92 | 7,011 | 48,516 | 11,006 | 4 K to 11 K (+175.49 %) |
| Dec 01 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.25 | 5,000 | 36,250 | 4,952 | |
| Dec 01 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 35.00 | 5,000 | 175,000 | 3,995 | 9 K to 4 K (-55.59 %) |
| Dec 01 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.25 | 5,000 | 36,250 | 8,995 | 4 K to 9 K (+125.16 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 5.00 | 4,953 | 24,765 | 0 | |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.25 | 5,047 | 36,591 | 9,952 | |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 24.25 | 4,953 | 120,110 | 3,995 | 8.9 K to 4 K (-55.35 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 5.00 | 4,953 | 24,765 | 8,948 | 4 K to 8.9 K (+123.98 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 24.25 | 5,047 | 122,390 | 3,995 | 9 K to 4 K (-55.82 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.25 | 5,047 | 36,591 | 9,042 | 4 K to 9 K (+126.33 %) |
| Feb 10 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | A | 17.14 | 47,000 | 805,580 | 47,000 | |
| Nov 08 2013 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | A | 12.49 | 30,000 | 374,700 | 30,000 | |
| Apr 16 2013 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | VP, Int. Head of Dr ... | Option Exercise | A | 6.96 | 60,000 | 417,600 | 60,000 |
Page: 1